Lifecore Biomedical Future Growth
Future criteria checks 4/6
Lifecore Biomedical is forecast to grow earnings and revenue by 138.1% and 15.1% per annum respectively while EPS is expected to grow by 138.3% per annum.
Key information
138.1%
Earnings growth rate
138.3%
EPS growth rate
Life Sciences earnings growth | 17.0% |
Revenue growth rate | 15.1% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 22 Apr 2024 |
Recent future growth updates
Recent updates
White Falcon Capital - Lifecore Biomedical: Potential For Rapid Growth In Earnings And FCF Surge
Apr 20Would Lifecore Biomedical (NASDAQ:LFCR) Be Better Off With Less Debt?
Jun 30Landec Non-GAAP EPS of -$0.32, revenue of $43.35M
Oct 06Landec receives Nasdaq's notification on delayed annual report filing
Sep 09Laughing Water Capital - Landec Corp. : A High Quality CDMO
Jul 27Landec (NASDAQ:LNDC) Takes On Some Risk With Its Use Of Debt
Jun 24Analysts Have Been Trimming Their Landec Corporation (NASDAQ:LNDC) Price Target After Its Latest Report
Apr 08Landec (NASDAQ:LNDC) Has A Somewhat Strained Balance Sheet
Mar 21Here's What's Concerning About Landec's (NASDAQ:LNDC) Returns On Capital
Nov 30Optimistic About Landec's Strategic Initiatives And Sodium Hyaluronate Products
Nov 05Landec Still In Play As An Activist Investment
Aug 20Is Landec (NASDAQ:LNDC) Using Too Much Debt?
May 25Is Landec (NASDAQ:LNDC) Using Too Much Debt?
Feb 24The CEO, President & Director of Landec Corporation (NASDAQ:LNDC), Albert Bolles, Just Bought 38% More Shares
Jan 20Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
5/31/2026 | 164 | N/A | N/A | N/A | 1 |
5/31/2025 | 145 | 19 | 15 | N/A | 2 |
5/31/2024 | 126 | 7 | 2 | N/A | 2 |
5/28/2023 | 103 | -64 | -39 | -17 | N/A |
2/26/2023 | 173 | -87 | -41 | -20 | N/A |
11/27/2022 | 183 | -78 | -46 | -25 | N/A |
8/28/2022 | 188 | -67 | -50 | -27 | N/A |
5/29/2022 | 111 | -15 | -53 | -23 | N/A |
2/27/2022 | 135 | -12 | -49 | -18 | N/A |
11/28/2021 | 142 | -7 | -37 | -8 | N/A |
8/29/2021 | 78 | -6 | -28 | -1 | N/A |
5/30/2021 | 101 | -23 | -9 | 16 | N/A |
2/28/2021 | 283 | -24 | -18 | -2 | N/A |
11/29/2020 | 391 | -34 | -2 | 16 | N/A |
8/30/2020 | 587 | -44 | -16 | 5 | N/A |
5/31/2020 | 160 | -22 | -44 | -17 | N/A |
2/23/2020 | 587 | -23 | -39 | -6 | N/A |
11/24/2019 | 590 | -10 | -46 | -4 | N/A |
8/25/2019 | 572 | -3 | -32 | 8 | N/A |
5/26/2019 | 558 | 2 | -29 | 16 | N/A |
2/24/2019 | 546 | 8 | -29 | 17 | N/A |
11/25/2018 | 535 | 23 | -24 | 18 | N/A |
8/26/2018 | 533 | 24 | -24 | 19 | N/A |
5/27/2018 | 524 | 26 | -14 | 20 | N/A |
2/25/2018 | 448 | 21 | -7 | 27 | N/A |
11/26/2017 | 440 | 8 | 3 | 31 | N/A |
8/27/2017 | 453 | 9 | 0 | 27 | N/A |
5/28/2017 | 470 | 10 | 7 | 30 | N/A |
2/26/2017 | 540 | 13 | N/A | 39 | N/A |
11/27/2016 | 534 | -12 | N/A | 25 | N/A |
8/28/2016 | 538 | -11 | N/A | 30 | N/A |
5/29/2016 | 477 | -12 | N/A | 21 | N/A |
2/28/2016 | 540 | -12 | N/A | 19 | N/A |
11/29/2015 | 549 | 13 | N/A | 25 | N/A |
8/30/2015 | 541 | 14 | N/A | 20 | N/A |
5/31/2015 | 539 | 14 | N/A | 27 | N/A |
3/1/2015 | 526 | 14 | N/A | 21 | N/A |
11/30/2014 | 514 | 17 | N/A | 20 | N/A |
8/31/2014 | 501 | 17 | N/A | 20 | N/A |
5/25/2014 | 477 | 19 | N/A | 21 | N/A |
2/23/2014 | 463 | 19 | N/A | 22 | N/A |
11/24/2013 | 454 | 18 | N/A | 23 | N/A |
8/25/2013 | 449 | 23 | N/A | 21 | N/A |
5/26/2013 | 442 | 23 | N/A | 21 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LFCR is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).
Earnings vs Market: LFCR is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: LFCR is expected to become profitable in the next 3 years.
Revenue vs Market: LFCR's revenue (15.1% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: LFCR's revenue (15.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if LFCR's Return on Equity is forecast to be high in 3 years time